step 4 semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial Once-weekly semaglutide 7·2 mg in

Its ability to heal tissues across systems-from gut ulcers to torn tendons-offers hope to millions suffering from chronic conditions

(Most women tend to gain 1.5 pounds per year and men tend to gain 12 pounds per year in midlife.) Current FDA guidelines recommend waiting until this latter person becomes sick or obese (or both) to treat them with a GLP-1 medication

Add high-stress corporate jobs and processed foods to the mix, and your cellular health takes a massive hit

Elevated NNMT expression has been observed in adipose tissue of animals with insulin resistance, and modulation of this enzyme has been shown to influence weight and metabolic function in preclinical models